Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Pharmaceutical Design, Volume 16 - Number 29







Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer

, 16(29): 3288 - 3299

Harun M. Said, Claudiu T. Supuran, Carsten Hageman, Adrian Staab, Buelent Polat, Astrid Katzer, Andrea Scozzafava, Jelena Anacker, Michael Flentje and Dirk Vordermark


DOI: 10.2174/138161210793429788


The β-Carbonic Anhydrases from Mycobacterium tuberculosis as Drug Targets

, 16(29): 3300 - 3309

Isao Nishimoria, Tomoko Minakuchia, Alfonso Marescab, Fabrizio Cartab, Andrea Scozzafava and Claudiu T. Supuran


DOI: 10.2174/138161210793429814




Saccharomyces cerevisiae β-Carbonic Anhydrase: Inhibition and Activation Studies

, 16(29): 3327 - 3336

Semra Isika, Ozen Ozensoy Guler, Feray Kockar, Meltem Aydin, Oktay Arslan and Claudiu T. Supuran


DOI: 10.2174/138161210793429878



Editor-in-Chief

William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)

Biography View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32

Advertisement

MANAGING MEDICAL WRITINGCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog